A first-in-human phase 1 study in healthy adult participants to assess safety, pharmacokinetics and pharmacodynamics of Ea3571
Latest Information Update: 30 May 2025
At a glance
- Drugs EA 3571 (Primary)
- Indications Non-alcoholic steatohepatitis
- Focus Adverse reactions; First in man; Pharmacodynamics; Pharmacokinetics
Most Recent Events
- 30 May 2025 New trial record